WES – Macquarie rates the stock as Underperform
Rating is downgraded to Underperform from Neutral. Target is reduced to $43.30 from $47.50.
Read MoreRating is downgraded to Underperform from Neutral. Target is reduced to $43.30 from $47.50.
Read MoreOn the ASX docket Thursday: IGO’s WSA takeover reaches its conclusion; a fairly nondescript investor presentation from Wesfarmers; and an old copper mine gets another life.
Read MoreThe Buy rating and target price of $56.00 are retained.
Read MoreIt’s far from a main earnings driver, but a rare update has confirmed that Wesfarmers’ half-owned lithium project in WA remains on track for first production in two years’ time.
Read MoreAnother busy day on the Australian bourse. Here’s the latest from some of the companies at the bigger end of town – Woodside Petroleum, Wesfarmers, Telstra and South32.
Read MoreWesfarmers’ takeover of Australian Pharmaceutical Industries has been given the greenlight to proceed after getting clearance from the competition regulator, the ACCC.
Read MoreWesfarmers shares rose sharply yesterday despite a substantial downgrade for sales growth and profits as Covid Omicron took a toll on sales in two key chains – Kmart and Officeworks.
Read MoreWesfarmers’ decision yesterday not to sell its 19% stake in API is seen by most market pundits as effectively being a blocking move against the bid from rival Woolworths.
Read MoreShares in API soared more than 16% on Thursday to a high of $1.74 after Woolworths crashed Wesfarmers’ attempt to take control of the company.
Read MoreThe Neutral rating is retained. Target is raised to $60.38 from $59.91.
Read MoreSigma’s attempt to snatch control of API appears to have been thwarted, with rival bidder Wesfarmers exercising its call option over 19.3% API shares to put it in a dominant blocking position.
Read MoreCompetition regulator the ACCC has given the greenlight for Wesfarmers’ hardware chain Bunnings to acquire national tile retailer Beaumont Tiles.
Read MoreSigma Healthcare has come over the top of Wesfarmers and made a non-binding cash and share offer for rival chemist Australian Pharmaceutical Industries that seems to have grabbed the lead in the battle.
Read MoreNeutral and $62 target retained.
Read MoreWesfarmers seems to have won the hearts and minds of the board and major shareholders of Australian Pharmaceutical Industries (API) with a lift in its proposed offer price from $1.38 cash to $1.55 a share.
Read MoreCiti continues to have a problem with the valuation, hence the Sell rating remains in place. Target price climbs to $49 from $47.
Read MoreRetail giant Wesfarmers has joined the list of companies rewarding their shareholders, announcing $2.3 billion in dividends after a solid financial year which saw profits jump 16%.
Read MoreAustralian Pharmaceutical Industries has told Wesfarmers to go away after rejecting the non-binding $1.38 a share offer as “opportunistic” and not in the best interests of shareholders.
Read MoreWesfarmers’ surprise $687 million, $1.38 per share bid for Australian Pharmaceutical Industries (API) could very well re-ignite a brawl over the big retailers getting into the business.
Read MoreThe broker retains a Neutral rating and lowers the target to $57.23 from $57.32 after a few minor adjustments to chemicals forecasts.
Read MoreThe broker retains a Neutral rating and raises the target of $57.32 from $57.04.
Read MoreAmid the sales surges experienced by Wesfarmers’ operations, Target seems to be heading towards a profitable June 30 year for the first time in quite a while.
Read MoreThe fortunes of Wesfarmers are increasingly tied (and the share price for that matter) to the performance of its Bunnings hardware chain, judging by the latest trading update for the Perth based giant.
Read MoreCredit Suisse upgrades forecasts, expecting the boost to household goods expenditure will be longer than previously anticipated. Wesfarmers is also positioned to add value through strategic acquisitions in the industrials and home improvement sectors.
Read MoreConsumers shopped in larger quantities, less frequently and increasingly online during the height of the nationwide lockdowns. The question now is: which trends will persist and which stocks will benefit as restrictions ease?
Read MoreWhile its Bunnings and Officeworks chains have had a good pandemic, a write-down on the value of its struggling target chain saw Wesfarmers report lower earnings for the year to June.
Read MoreCredit Suisse expects the company’s retail market position and solid trading through the fourth quarter will support the FY20 results, due on August 20.
Read MoreSales activity at Bunnings and Officeworks has been stunning over the period of pandemic-related restrictions but signals there is very little operating leverage for Wesfarmers going forward.
Read MoreA second trading update from Wesfarmers in just under three weeks with the company telling the market it has been seeing significant demand growth in its Bunnings and Officeworks businesses as well as online (like so many other retail-based companies).
Read MoreCredit Suisse suggests the restructuring of Target is unlikely to shift investor views regarding Wesfarmers. The company will spend $240-310m on the restructuring.
Read MoreScott Kelly, Manager of the DNR Capital Australian Equities Income Portfolio, provides an update on his firm’s outlook for dividends in the Australian equity market.
Read MoreWhat can Wesfarmers do with its underperforming chain, Target? Brokers suggest the laggard of the group may be in line for a severe reassessment.
Read MoreWesfarmers says it will fast track its review of struggling department store Target in the wake of a sharp fall in sales through the retailer so far in April.
Read MoreUBS cuts forecasts for Wesfarmers by -4-16% as well as updates for the sell-down of the Coles stake.
Read MoreWesfarmers has raised $1.060 billion from another sale of part of its stake in Coles Group. Wesfarmers said it had sold 5.2% of Coles at $15.39 a share.
Read MoreMajor women’s fashionwear retailer Mosaic Brands has become the latest chain operator to shut stores and stand down staff indefinitely. Casino operator, Star Group has also stood down around 90% of its staff of 9,000 while Wesfarmers has shut its Kmart stores in New Zealand as the coronavirus outbreak continues to escalate.
Read MoreWesfarmers shares rose more than 3% yesterday after it reported a moderately encouraging first half result, marred by an underpayments scandal to some staff.
Read MoreRetailing conglomerate Wesfarmers has joined Woolworths, Super Auto and Coles (which used to be a part of the conglomerate) in revealing a multi-million dollar underpayment to staff.
Read MoreWesfarmers is scheduled to report on February 19, and Credit Suisse anticipates a “solid” performance despite some industrials issues. Sales growth at Bunnings is believed to be accelerating and Kmart, despite overall tough conditions for retail, should come out well, assisted by logistics problems in the past.
Read More